Since APOE4 is the greatest genetic risk factor for late-onset AD, it would be interesting to perform a single-nucleus profiling analysis in APOE4 carriers to determine how this isoform impact the transcriptome of the various cell types, including microglia and astrocytes. This evidence concerns the gene APOE and Alzheimer disease.